microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft united states personal investing trowepricecom personal investing workplace retirement institutional investor institutional consultant financial advisorintermediary recordkeeping sponsorconsultant log out log in open an account about us help my accounts portfolio transactions statements  documents profile mutual funds daily prices historical performance dividend distributions mutual fund research tool morningstar  and star rated funds stock funds bond funds target date funds asset allocation funds money market funds prospectuses  reports retirement ira rollover ira retirement planning required minimum distributions small business retirement plans b plans planning  research advice investing  asset allocation planning retirement planning college planning tax planning estate planning research  analysis t rowe price insights planning  resources charitable giving products  services activeplus portfolios college savings plans non retirement accounts private asset management select client services advisory planning services brokerage investor centers t rowe price value fund trvlx home  mutual funds t rowe price value fund print this page email this page text size new quarterly fund fact sheet now available ticker symbol trvlx fund status open to new retail investors    open to subsequent retail investments snapshot objective performance composition management expensesminimums compare fund snapshot quick stats current nav as of   nav change  daily ytd return as of   nav  month lowhigh    net assets as of   million morningstar ratings as of  overall  year  year  year morningstar rated the value fund among    and  large value funds for the overall rating and the   and year periods as applicable ending  respectively the overall morningstar rating for a managed product is derived from a weighted average of the performance figures associated with its three five and year if applicable morningstar rating metrics the weights are  threeyear rating for  months of total returns  fiveyear rating threeyear rating for  months of total returns and  year rating fiveyear rating threeyear rating for  or more months of total returns while the year overall star rating formula seems to give the most weight to the year period the most recent threeyear period actually has the greatest impact because it is included in all three rating periods performance comparison as of  this chart shows the value of a hypothetical  investment in the fund over the past  years or since its inception for funds lacking year records the result is compared with benchmarks which may include a broadbased market index and a peer group average or index market indexes do not include expenses which are deducted from fund returns as well as mutual fund averages and indexes benchmark definitions  the morningstar rating for funds or star rating is calculated for managed products including mutual funds variable annuity and variable life subaccounts exchangetraded funds closedend funds and separate accounts with at least a threeyear history exchangetraded funds and openended mutual funds are considered a single population for comparative purposes it is calculated based on a morningstar riskadjusted return measure that accounts for variation in a managed products monthly excess performance placing more emphasis on downward variations and rewarding consistent performance the top  of products in each product category receive  stars the next  receive  stars the next  receive  stars the next  receive  stars and the bottom  receive  star the overall morningstar rating for a managed product is derived from a weighted average of the performance figures associated with its three five and year if applicable morningstar rating metrics the weights are  threeyear rating for  months of total returns  fiveyear rating threeyear rating for  months of total returns and  year rating fiveyear rating threeyear rating for  or more months of total returns while the year overall star rating formula seems to give the most weight to the year period the most recent threeyear period actually has the greatest impact because it is included in all three rating periods source for morningstar data   morningstar inc all rights reserved the information contained herein  is proprietary to morningstar andor its content providers  may not be copied or distributed and  is not warranted to be accurate complete or timely neither morningstar nor its content providers are responsible for any damages or losses arising from any use of this information past performance is no guarantee of future results average annual total returns and benchmarks as of  benchmark definitions investment objective the fund seeks to provide longterm capital appreciation by investing in common stocks believed to be undervalued income is a secondary objective average annual total returns    monthend  quarterend   year    years    years    years   since inception   inception date september   gross expense ratio  net expense ratio  waiver type na limitation expires na current performance may be lower or higher than the quoted past performance which cannot guarantee future results share price principal value and return will vary and you may have a gain or loss when you sell your shares  average annual total return figures include changes in principal value reinvested dividends and capital gain distributions for funds less than one year old the since inception return figure is not annualized and represents an aggregate total return  the gross expense ratio reflects the fund expenses as stated in the fee table of the funds prospectus prior to the deduction of any waiver or reimbursement the net expense ratio reflects fund expenses after the deduction of any waiver or reimbursement if a fund has an active contractual expense ratio limitation the expiration date is shown below the gross and net expense ratio values above expense ratios are as of the most recent prospectus open an account transact  trade viewupdate accounts help center find a fund select fund by name africa  middle east  i cl africa  middle east fund asia opportunities asia opportunities  i cl balanced balanced  i cl blue chip growth blue chip growth  i cl california taxfree bond california taxfree bond  i cl california taxfree money california taxfree money  i cl capital appreciation capital appreciation  i cl capital opportunity capital opportunity  i cl cash reserves corporate income corporate income  i cl credit opportunities credit opportunities  i cl diversified midcap growth diversified midcap growth  i cl dividend growth dividend growth  i cl dynamic global bond dynamic global bond  i cl em mkts corporate bond  i cl em mkts local currency bond  i cl emerging europe emerging europe  i cl emerging markets bond emerging markets bond  i cl emerging markets corporate bond emerging markets local currency bond emerging markets stock emerging markets stock  i cl emerging markets value stock emerging markets value stock  i cl equity income equity income  i cl equity index  equity index   i cl european stock european stock  i cl extended equity market index financial services financial services  i cl floating rate floating rate  i cl georgia taxfree bond georgia taxfree bond  i cl global allocation global allocation  i cl global consumer global growth stock global growth stock  i cl global high income bond global high income bond  i cl global industrials global industrials  i cl global multisector bond global multisector bond  i cl global real estate  i cl global real estate fund global stock global stock  i cl global technology  i cl global technology fund gnma gnma  i cl government money government money  i cl growth  income growth  income  i cl growth stock growth stock  i cl health sciences health sciences  i cl high yield high yield  i cl inflation protected bond inflation protected bond  i cl intermediate taxfree high yield intermediate taxfree hy  i cl international bond international bond  i cl international concentrated eq  i cl international concentrated equity international discovery international discovery  i cl international equity index international stock international stock  i cl international value equity international value equity  i cl japan japan  i cl latin america latin america  i cl limited duration inflation focused bd lmtd duration infl focused bd  i cl maryland shortterm taxfree bond maryland shortterm txfr bnd  i cl maryland taxfree bond maryland taxfree bond  i cl maryland taxfree money maryland taxfree money  i cl media  telecommunications media  telecommunications  i cl midcap growth midcap growth  i cl midcap value midcap value  i cl new america growth new america growth  i cl new asia new asia  i cl new era new era  i cl new horizons new horizons  i cl new income new income  i cl new jersey taxfree bond new jersey taxfree bond  i cl new york taxfree bond new york taxfree bond  i cl new york taxfree money new york taxfree money  i cl overseas stock  i cl overseas stock fund personal strategy balanced personal strategy balanced  i cl personal strategy growth personal strategy growth  i cl personal strategy income personal strategy income  i cl qm global equity qm global equity  i cl qm us small  midcap core eq  i cl qm us small  midcap core equity qm us smallcap growth equity qm us smallcap growth equity  i cl qm us value equity qm us value equity  i cl real assets real assets  i cl real estate real estate  i cl retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement balanced fund retirement balanced i  i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement income  science  technology science  technology  i cl shortterm bond shortterm bond  i cl smallcap stock smallcap stock  i cl smallcap value smallcap value  i cl spectrum growth spectrum income spectrum international summit municipal income summit municipal intermediate summit municipal money market target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl taxefficient equity  i cl taxefficient equity fund taxexempt money taxexempt money  i cl taxfree high yield taxfree high yield  i cl taxfree income taxfree income  i cl taxfree shortintermediate taxfree shortintermediate  i cl total equity market index total return total return  i cl us bond enhanced index us high yield us high yield  i cl us largecap core  i cl us largecap core fund us treasury intermediate us treasury intermediate  i cl us treasury longterm us treasury longterm  i cl us treasury money us treasury money  i cl ultra shortterm bond ultra shortterm bond  i cl value value  i cl virginia taxfree bond virginia taxfree bond  i cl select by ticker symbol gtfbx mdxbx njtfx nytxx otcfx otiix pbdix pccox pctxx pdgix pexmx pglox pgmsx pgtix pieqx pnaix pnsix pomix ppipx prafx pramx prasx prcix prcnx prcox prcpx prdgx prdmx prdsx prefx preix prelx premx presx prfdx prfhx prfrx prfsx prgfx prgix prgmx prgsx prgtx prhix prhsx prhyx pridx prihx prijx prikx prinx pripx prisx pritx priux prjix prjpx prkix prlax prmdx prmsx prmtx prnex prnhx prnyx prpix prrxx prscx prsgx prsix prsmx prsnx prsvx prtax prtix prtxx prufx pruix prulx pruux prvax prvix prwax prwbx prwcx prxax prxcx prxex prxix przix psilx ptexx ptkix pttfx ptyix rbaix rclix reipx revix rggix ricix rjaix rlaix rpbax rpeix rpgax rpgex rpgix rpgrx rpibx rpiex rpihx rpisx rpmgx rpoix rpsix rptfx rptix rpttx tbcix tbgax tbsix tcbxx tcfex tcrrx tecix teefx teimx terxx teuix tfaix tfbix tfbvx tfhax tfifx tfilx tfrrx tgafx tgipx tgtix thisx ticcx tiddx tiipx tirgx tirrx tmdxx toorx torfx tpgpx tppax tqaix tqgex tqgix tqmvx tqsix tqsmx tqvix traix tramx traox trarx trasx trbcx trbfx trbrx trbux trecx tremx trffx trfgx trfox trfwx trgax trglx trgrx trgxx trhrx trigx trjix trlax trldx trmcx trmix trmux trnex trnxx troix trosx trpax trpbx trpcx trpdx trpfx trphx trpix trpjx trpkx trplx trpmx trpnx trppx trptx trrax trrbx trrcx trrdx trrex trrfx trrgx trrhx trrix trrjx trrkx trrlx trrmx trrnx trrox trrtx trrux trrvx trrwx trsgx trstx trsxx trtfx trtix trulx trvlx trvvx trxrx tryix tscxx tsnix tteex ttgxx ttmix ttoix ttrtx ttsix tturx tuhix tuhyx twnxx twrrx more fund information download a prospectus download a semiannual report download an annual report download statement of additional information yearend dividend distributions yearend tax considerations dividend distribution dates   related links also available to certain investors as a lower cost i class mutual fund our mission is simple help clients around the world achieve their longterm investment goals connect with us facebook twitter youtube linkedin company overview responsibility careers investor relations press releases site map privacy policy terms of use security measures legal information customer agreement feedback mobile solutions contact us the mutual funds referred to in this website are offered and sold only to persons residing in the united states and are offered by prospectus only the prospectuses include investment objectives risks fees expenses and other information that you should read and consider carefully before investing download a prospectus wed jul   edt  all rights reserved t rowe price investment services inc distributor t rowe price mutual funds t rowe price invest with confidence and the bighorn sheep design are trademarks of t rowe price group inc all other trademarks are the property of their respective owners morningstar  and star rated funds  mutual funds  t rowe price  t rowe price home mutual funds morningstar  and star rated funds over  of our funds have earned  or star overall morningstar ratings as of  invest now call us at  download a prospectus morningstar  and star rated funds stock funds us stock funds international and global stock funds bond funds us bond funds international and global bond funds target date funds retirement funds target funds income funds asset allocation funds money market funds find a fund browse all t rowe price mutual funds many of our mutual funds earn morningstar’s highest ratings morningstar  and star rated funds because of our disciplined approach to investing morningstar a leader in independent investment research recognizes many of our mutual funds with its highest ratings in the funds respective categories over  of our funds have earned  or star overall morningstar ratings as of  morningstar uses a star system to rate mutual funds based on their riskadjusted returns five stars is the highest while one star is the lowest rating only the top  of all funds of the   get  stars and  get  stars are awarded morningstars  or star rating by comparison as of   of  of our rated funds investor class only received an overall rating of  or  stars​ past performance cannot guarantee future results view all  and star rated funds explore morningstar  and star rated funds fund nameticker morningstarcategory overall morningstarrating™ no offunds incategory riskrewardpotential fund name ticker morningstar category overall morningstar rating™ no of funds in category riskreward potential compare morningstar  and star rated funds find a fund browse all t rowe price mutual funds t rowe price insightsreg markets  economy monthly market review stay informed about global economic developments and our perspective on market conditions read more   source t rowe price markets  economy global markets weekly update keep uptodate on our views on developments in global capital markets read more july    source t rowe price all mutual funds are subject to market risk including possible loss of principal morningstar gives its best ratings of  or  stars to the top  of all funds of the   get  stars and  get  stars based on their riskadjusted returns the overall morningstar rating™ is derived from a weighted average of the performance figures associated with a funds   and year if applicable morningstar rating™ metrics as of   of  of our rated funds investor class only received an overall rating of  or  stars the morningstar ratingtm for funds or star rating is calculated for funds with at least a threeyear history exchangetraded funds and openended mutual funds are considered a single population for comparative purposes it is calculated based on a morningstar riskadjusted return measure that accounts for variation in a managed products monthly excess performance placing more emphasis on downward variations and rewarding consistent performance the top  of products in each product category receive  stars the next  receive  stars the next  receive  stars the next  receive  stars and the bottom  receive  star source for morningstar data  morningstar inc all rights reserved the information contained herein  is proprietary to morningstar andor its content providers  may not be copied or distributed and  is not warranted to be accurate complete or timely neither morningstar nor its content providers are responsible for any damages or losses arising from any use of this information past performance is no guarantee of future results this chart displays relative risk of each us mutual fund listed using standard deviation of returns those values are provided in the bars at the top of the chart methodology we evaluate the standard deviation and its resulting placement within a specific riskreturn category on an annual basis a fund is generally placed in a riskreturn category based on the year standard deviation of its performance if a fund is less than  years old the actual fund performance history is supplemented with the primary prospectus benchmark history to obtain a full year history or longest time period available up to  years for an asset allocation fund with less than  years of performance history substrategy returns are used when a substrategy is less than  years old the actual substrategy performance history is supplemented with benchmark history to obtain a full year history or longest time period available up to  years risk return categories overlap a fund with a standard deviation in the overlap between two categories denoted by a plus  is placed so that its risk categorization is better aligned with anticipated return characteristics an investor may experience going forward at the discretion of t rowe price when a fund has a cashlike benchmark denoted by a double plus  its standard deviation is estimated using only available fund returns if the fund is less than  years old benchmark returns are not used to obtain a full year history because they would artificially suppress the volatility estimate all investments are subject to market risk including the possible loss of principal standard deviation of returns a measure of price volatility is one measure of risk please consult the funds’ prospectuses for a more complete discussion of the funds’ risks  california taxfree money fund capital appreciation fund equity income fund global allocation fund global industrials fund gnma fund inflation protected bond fund international bond fund international stock fund japan fund limited duration inflation focused bond fund new era fund personal strategy balanced fund personal strategy income fund qm global equity fund qm global equity fund qm us value equity fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund shortterm bond fund spectrum international fund summit municipal intermediate fund target  fund target  fund target  fund target  fund target  fund taxfree shortintermediate fund total equity market index fund ultra shortterm bond fund  global unconstrained bond fund roth or traditional ira  t rowe price home retirement ira roth or traditional ira roth or traditional ira compare roth and traditional iras roth ira traditional ira roth or traditional ira rollover and transfer iras navigate to roth ira traditional ira roth or traditional ira rollover and transfer iras when it comes to making a thoughtful decision between a roth ira and a traditional ira it helps to understand the differences   roth ira traditional ira taxes contributions made are not deductible contributions made can be taxdeductible or nondeductible deductibility of contributions depends on active participation in a retirement plan and your modified adjusted gross income magi not exceeding certain amounts withdrawal of contributions withdraw anytime without taxes or penalties withdraw anytime but deductible contributions are taxable and generally subject to penalties if withdrawn before age ½ withdrawal of earnings tax and penaltyfree when withdrawn at age ½ if account has been active for at least five years taxable when withdrawn and generally subject to penalties if withdrawn before age ½ age restrictions none   must be under age ½ during the tax year of the contribution eligibility may contribute only if depending on filing status magi does not exceed certain amounts you must have us earned income no restrictions on contributions you must have us earned income   required minimum distributions rmds none during your lifetime must begin taking for the year in which you reach age ½ ready to start call  open a roth ira open a traditional ira still unsure about roth vs traditional answer four questions to find out which ira may be right for you why t rowe price for a roth or traditional ira low fees and minimums   you need to maximize your return potential so we work to keep our fees competitive thats why our solutions include noload mutual funds with low expense ratios keep in mind that a traditional iraroth ira may be subject to an annual fee and a fee may be assessed when a traditional iraroth ira is closed heres more information on fees convenient and flexible fund choices   you can choose from target date funds with strategic asset allocation and diversification or select from more than  mutual funds to suit your investing needs download a prospectus a global investing network in pursuit of your goals   our highly tenured global investment professionals are continuously assessing potential risk while identifying opportunities to maximize growth potential over the long term so you have more money in retirement  want to move existing savings into a roth ira roll over a k a rollover ira is one of several options to consider for your former workplace retirement plan such as a k   explore your options roll over now   transfer an existing ira if you decide to transfer an ira we offer over  mutual funds from which to choose and we make it easy by handling most of the paperwork too transfer an ira now convert your t rowe price traditional ira to a roth ira a roth ira offers many advantages over a traditional ira like potentially taxfree withdrawals if you need them convert now  page not found page not found we apologize for any inconvenience but we are unable to locate the page you requested this could be due to either of the reasons below if you manually entered the url please make sure it is correct check that the capitalization matches that all words are spelled correctly and that all the punctuation like periods  and slashes  are correctly placed be sure that you are using the forward slash  and not the backward slash  remember there are no spaces in urls if you have bookmarked this page this page may have been renamed moved or deleted please return to our homepage and reset your bookmarks biotechnology value fund lp private company information  bloomberg july    am et capital markets company overview of biotechnology value fund lp snapshot people company overview biotechnology value fund lp is a hedge fund launched and managed bvf partners lp it invests in biotechnology sector biotechnology value fund lp was formed in  and is domiciled in the united states one sansome streetth floorsan francisco ca united statesfounded in  phone  fax  key executives for biotechnology value fund lp mr mark n lampert founder manager and president age  mr matthew d perry portfolio manager age  compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target private placement november   fate therapeutics inc mergeracquisition september   tobira therapeutics inc request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states the advertising council inc united states bertelsmann ag europe rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact biotechnology value fund lp please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close biotechnology value fund lp company profile bioportfolio biotech healthcare and medical resources advertisement topics all topics biotechnology biotech business biotech products cancer cardiovascular dermatology drug discovery endocrinology gastroenterology immunology infectious diseases mental health neurology obstetrics orthopedics public health respiratory rheumatology urology  track topics on twitter track topics that are important to you printed from bioportfoliocom biotechnology value fund lp company profile  edt th july   bioportfolio news articles  associated news articles listed on bioportfolio encouraging signs for a big biotech etf the ishares nasdaq biotechnology etf  the largest biotechnology exchange traded fund by assets is up nearly  yeartodate indicating biotechnology is playing a pivotal role in the broader health big biotech etf bounce looks for more upside the ishares nasdaq biotechnology etf  the largest biotechnology exchange traded fund by assets is up more than  over just the past month resurgent biotechnology stocks and etfs have been fueled  new french biotech seed fund raises €m in its first closing advent france biotechnology has launched its first seed fund for life sciences with the support of bpifrance and advent life sciences  advent france biotechnology founded in  has exceeded its  biotech etf ibb on pace for best weekly gain  months a popular fund used to invest in the biotechnology sector on thursday was on track for its best weekly gain in seven months according to factset data the ishares nasdaq biotechnology etf was up  korea announces  mn fund for bio startups biospectrum the fund will be floated to help young jobseekers launch new startups and develop new biotechnology read m week in review cbridge raises  million for second china healthcare fund bridge capital a china private equity firm with a life science focus closed its second fund cbridge healthcare fund ii at its  million cap cbridge plans to invest in latestage companies in is the biotech sector preparing for another major rally  watch this chart biotechnology stocks had an incredible run between  and  and the ishares nasdaq biotechnology etf was up  in that time after making the record high however the space came under pressur news biotech canaan unveils m fund for fresh wave of biotech bets biotechnology pharma and biopharma news – research – science – lifescience biotechbiopharmapharma canaan unveils m fund for fresh wave of biotech bets canaan has put toge drugs and medications  associated drugs and medications listed on bioportfolio korres quercetin  oak hydrating antiageing and antiwrinkle johnson  johnson consumer products company division of johnson  johnson consumer companies inc korres quercetin  oak day cream for normal to dry skin spf  bioactive antiaging sipres srl bioactive antiaging cream multiprotection daily renewal spf  advanced double lifting effect biodynamic skin sipres srl biodynamic skin solution pubmed articles  associated pubmed articles listed on bioportfolio does the public prefer health gain for cancer patients a systematic review of public views on cancer and its characteristics policies such as the cancer drugs fund in england assumed a societal preference to fund cancer care relative to other conditions even if that resulted in lower health gain for the population overall editorial overview systems biology for biotechnology special issue of new biotechnology in memory of professor brian fc clark  in memory of professor brian f c clark tribute by mike taussig editor in chief new biotechnology editorial overview environmental biotechnology clinical trials  associated clinical trials listed on bioportfolio a pilot scheme  specimen collection of health management center biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future the development of biomedical depends on a high quality academic resea stivarga real life evidence in hungary the study aims to evaluate use of regorafenib in clinical practice in hungary the study should provide information about clinical characteristics of hungarian regorafenib patients as well a phase iii clinical trial of a valent pneumococcal conjugate vaccine in healthy infants in order to evaluate immunogenicity and safety of a valent pneumococcal conjugate vaccine produced by beijing minhai biotechnology co ltd a randomized doubleblind parallelcontro result reliable emergent solution using liprotamase treatment liprotamase powder is a nonporcine soluble and stable mixture of biotechnologyderived lipase protease and amylase digestive enzymes the purpose of the present study is to to evaluate observational cohort of hiv infected adults and children in the phpt network hospitals in thailand since  the thai ministry of public health has massively scaled up antiretroviral treatment programs to provide therapy to more than  patients with partial support of the global  companies  associated companies listed on bioportfolio biopharma fund biopharma fund is an investment fund that invests in shares of medical biotechnology companies biotechnology companies are developing new drugs for many diseases such as cancer heart disease diabet hatchtech hatchtech pty ltd is a venturebacked specialty pharmaceutical product company that is developing technology for the control of invertebrate pests the companyâs investors in longwood founders fund lp longwood founders fund is a healthcare venture capital firm that founds manages and builds biotechnology companies longwoodâs mission is to identify technologies and to fo biotechnology value fund lp the assistance fund the assistance fund is an independent charitable patient assistance foundation that helps patients and families facing high medical outofpocket costs by providing financial assi more information about biotechnology value fund lp on bioportfolio we have published hundreds of biotechnology value fund lp news stories on bioportfolio along with dozens of biotechnology value fund lp clinical trials and pubmed articles about biotechnology value fund lp for you to read in addition to the medical data news and clinical trials bioportfolio also has a large collection of biotechnology value fund lp companies in our database you can also find out about relevant biotechnology value fund lp drugs and medications on this site too quick linksadvanced search  login  subscribe  rss quick search advertisement   corporate database quicklinks search corporate database latest corporate records biotech companies by location popular company records recent company searches add or control your corporate profile searches linking to this company recordbiotechnology value fund partners equity holdingsbiotechnology value partners linkedin bioportfolio limited about us contact us social media twitter  accounts twitter google linkedin publish content publish publish your press release advertise agreements agreements medical disclaimer privacy tools mybioportfolio rss help faqs sitemaps xml sitemap this site complies with the honcode standard for trustworthy health information verify here the information provided by bioportfoliocom is not a substitute for professional medical advice diagnosis or treatment the bioportfolio site is sponsored bioportfolio limited with offices at stafford house  prince of wales road dorchester dt pw england if you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “fair use” and legitimately infringes on your or your clients copyright we may be contacted concerning copyright matters at prioritybioportfoliocom all rights reserved all other trademarks recognized copyright   bioportfolio limited site developed by alacrify ltd biotechnology pharmaceutical and healthcare company and supplier directorylisting bioportfolio biotech healthcare and medical resources advertisement topics all topics biotechnology biotech business biotech products cancer cardiovascular dermatology drug discovery endocrinology gastroenterology immunology infectious diseases mental health neurology obstetrics orthopedics public health respiratory rheumatology urology  track topics on twitter track topics that are important to you printed from bioportfoliocom biotechnology pharmaceutical and healthcare company and supplier directorylisting  edt th july   bioportfolio the bioportfolio corporate directory has been designed for three groups of users the professional executive the researcher and the general investor  the directory lists over  healthcare pharmaceutical and biotechnology companies worldwide involved in research development manufacturing and related services  companies can be sorted by keyword and each profile provides related press releases and clinical trials  for example cancer companies corporates  ngos  how to subscribe to ensure your profile is uptodate with the latest news and products bioportfolio provides a unique window to the global audience of business professionals corporate and public researchers and consumers with an appetite for biotechnology pharmaceutical and healthcare information  as a biocorportate subscriber bioportfolio will work with you via a dedicated account manager to ensure that we optimize relevant information on your organization published on the site maintain your corporate profile  upto  words images urls etc eg genentech inc promote your products and services  upto  entries each with a unique channel web page eg vantictumab publication of your press releases  upto  press releases can be submitted for review and publication  see bionewscast your rss feeds  events press blogs etc added to our global news service social media  weekly tweets to our targeted twitter accounts contact pressreleasesbioportfoliocom search companies only by keyword relevance date showing companies – of  wednesday th july  mach technologies inc mach technologies asxmt develops innovative enterprise imaging it solutions that create a clear and complete view of the patient to inform diagnosis reduce care delivery delays and costs and improve patient outcomesâ machâs awardwinning enterprise imaging platform provides a vendor neutral foundation for unstructured data consolidation and  sailpoint technologies inc sailpoints awardwinning identity governance software sailpoint identityiqtm helps organizations gain control over user access to critical systems and data streamline costly it compliance processes and reduce the risks of fraud corporate data loss or theft and failed audits sailpoints customers are global  organizations focused on compliance and risk mitigation initiatives including  evolve formulas llc avizia inc newegg inc newegg inc is the leading electronicsfocused eretailer in the united states it owns and operates neweggcom httpwwwneweggcom which was founded in  and regularly earns industryleading customer service ratings the awardwinning website has more than  million registered users and offers customers a comprehensive selection of the latest cons glucose health inc glucose health inc dietary products engage the large and growing market of consumers aware of the seriousness of type  diabetes and proactively seeking natural blood sugar health solutions the cdc currently estimates  in  adults â  million americans â will develop type  diabetes in their lifetime glucose health inc dietary products ar trina health midwest signature medical inc zglobal inc zglobal offers a wide range of services in the energy sector including roundtheclock scheduling and operation services and reliabilitycompliance services for several large solar geothermal and biomass facilities and utilities throughout the western united states zglobal was formed in  and is staffed by veterans both from the california independe tuesday th july  black beret life sciences llc rodman  renshaw capital group inc rodman  renshaw a unit of hc wainwright  co llc is an investment bank dedicated to providing corporate finance strategic advisory research sales and trading and other related services to public and private growth companies across multiple focuses and regions rodman  renshaw is headquartered at  park avenue new york ny  betterback launched in  betterback allows you to effortlessly sit in perfect posture easing back painâand preventing it lightweight and portable you can pull it out of a handbag to make every single chair ergonomic wearing it for just  minutes a day can retrain your bodyâs default posture so when you stand or sit without betterback your posture is  bryan health bryan health is a nebraskagoverned nonprofit health system that cares for patients educates tomorrowâs health care providers and motivates communities with fitness and health programs with an awardwinning network of doctors hospitals and medical providers bryan health offers effective care works with industry leaders to introduce leadingedge  spinal kinetics inc founded in  spinal kinetics is a privately held medical device company focused on partnering with spine surgeons to develop innovative and practical motion preservation systems for treating degenerative diseases of the spine the mc cervical and ml lumbar artificial discs have rapidly established themselves among the leading artificial discs avail clinicalstudydatarequestcom clinicalstudydatarequestcom is the industry leader in global clinical trial data transparency its multisponsor request system provides a secure process for researchers to request access to global clinical trial data through a publicly available website an independent review panel and process overseen by the wellcome trust review data requests received  accessone founded in  accessone is a leading provider of patient financing options designed to help patient consumers manage their healthcare costs while driving best in class hospital reimbursement accessone offers comprehensive low and no interest payment options for all patient balance types including highdeductible catastrophic and financial assistance  hca healthcare inc nashvillebased hca healthcare is one of the nations leading providers of healthcare services operating  locally managed hospitals and  freestanding surgery centers in  states and the united kingdom with its founding in  hca created a new model for hospital care in the united states using combined resources to strengthen hospitals deliver  onedigital health and benefits onedigital the nationâs largest company focused exclusively on employee benefits combines people and technology to deliver the new generation of health and benefits it provides fresh thinking ahead of the market innovative approaches and marketleading solutions that give clients peace of mindâ serving companies of all sizes onedigital offers  venatorx pharmaceuticals inc venatorx pharmaceuticals is a private pharmaceutical company dedicated to the discovery and development of novel agents to address the threat of antibiotic bacteria resistance its lead clinical program combines vnrx a novel î²lactamase inhibitor with an approved and marketed î²lactam antibiotic this press release contains âforwardlooking  shape memory medical inc shape memory medical inc based in santa clara california is committed to developing multiple medical therapies with their novel shape memory polymers for embolization visit wwwshapememcom codiagnostics inc codiagnostics inc a utah corporation is a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests that function via the detection andor analysis of nucleic acid molecules dna or rna and to sell diagnostic equipment from other manufacturers as selfcontained lab systems venebio group venebio is a research consultancy that provides costeffective custom solutions for complex life sciences problems by integrating the expertise of a global network of scientists in a broad range of biomedical fields venebio delivers comprehensive project management and problem solving in genetic and molecular epidemiology pharmacoepidemiology and pharm alpine immune sciences inc alpine immune sciences inc was founded in  and is focused on developing novel proteinâbased immunotherapies using its proprietary variant immunoglobulin domain vigd platform technology the vigd platform is designed to create novel therapeutics that modulate multiple therapeutic targets including many present in the immune synapse alpines v rebound therapeutics rebound has progressed rapidly over the past  months having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive surgical procedures in addition to rapid product development of its initial products rebound has assembled a worldclass scientific advisory board of leading mis physicians filed  histogen inc histogen is a regenerative medicine company developing innovative products from cells grown under simulated embryonic conditions including low oxygen and suspension through this unique technology process newborn cells are directed to naturally produce vital proteins and growth factors from which the company has developed its rich product portfolio hist … more from bioportfolio on  related companiesrelated eventsrelated clinical trialsrelated pubmed entriesrelated medications quick linksadvanced search  login  subscribe  rss quick search advertisement   corporate database quicklinks search corporate database latest corporate records biotech companies by location popular company records recent company searches add or control your corporate profile bioportfolio limited about us contact us social media twitter  accounts twitter google linkedin publish content publish publish your press release advertise agreements agreements medical disclaimer privacy tools mybioportfolio rss help faqs sitemaps xml sitemap this site complies with the honcode standard for trustworthy health information verify here the information provided by bioportfoliocom is not a substitute for professional medical advice diagnosis or treatment the bioportfolio site is sponsored bioportfolio limited with offices at stafford house  prince of wales road dorchester dt pw england if you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “fair use” and legitimately infringes on your or your clients copyright we may be contacted concerning copyright matters at prioritybioportfoliocom all rights reserved all other trademarks recognized copyright   bioportfolio limited site developed by alacrify ltd biotechnology value fund lp  chicago il  company information products resources my account talk to a db advisor  business directory il chicago investment advice investment advice biotechnology value fund lp b biotechnology value fund lp claim this business  n michigan ave   chicago il  get directions business info founded  incorporated annual revenue  employee count  industries investment advice contacts michael sacks contact business your email address subject message send message company summary since  biotechnology value fund lp has been providing investment advice from chicago biotechnology value fund lp has estimated annual revenues of  and also employs an estimated  employees verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   b view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved bvf partners lp san francisco  investing in smallcap biotechnology companies skip to content javascript must be enabled for the correct page display contact us bvf partners lp is a san franciscobased private investment partnership specializing in fundamentallydriven public biotechnology investments since its inception in  bvf has strived to build concentrated longterm investments in smallcap biotechnology companies while performing rigorous diligence and ongoing monitoring of its investments bvf is committed to working with its portfolio companies as partners in their successes bvf partners lp one sansome street th floor san francisco ca    bvf partners lp this website is for informational purposes only and does not constitute an offer or the solicitation of any securities or investment management or investment advisory services by bvf partners lp or any of its affiliates any such offer may be made only by way of delivery of certain disclosure materials relating to bvf partners lp and its investment process including part a of its us securities and exchange commission form adv alternative investing is speculative and involves substantial risk including the possible loss of the entire amount invested no assurance can be given that any investment account managed or advised by bvf partners lp will achieve its objectives or avoid losses past performance is not necessarily indicative of future results and the performance of any investment account managed or advised by bvf partners lp could be volatile back to top ﻿ biotechnology value fund l p just bought globeimmune inc stake – octafinance wednesday  july  menu featured news  years ago  alphabet inc nasdaqgoogl tests its ad technology on billboards to cushion itself against ad blocks  years ago  china margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisis  years ago  marc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and gold  years ago  carl icahn criticizes the fed feels bad for investors buying junk bonds  years ago  john burbank european qe can’t save the markets same as the us quantitative easing everything will be liquidated biotechnology value fund l p just bought globeimmune inc stake  by octastaff in sec g  d filings share with your friendsyour nameyour emailrecipient emailenter a messagei read this article and found it very interesting thought it might be interesting for you the article is called biotechnology value fund l p just bought globeimmune inc stake and is was published by octafinancecom at httpwwwoctafinancecombiotechnologyvaluefundlpjustboughtglobeimmuneincstakecaptchasubmitbiotechnology value fund l p new position in globeimmune inc nasdaqgbim biotechnology value fund l p has filled a sc g form regarding globeimmune inc    filing link  per biotechnology value fund l p’s filing the filler now owns  of the company holding  shares globeimmune inc nasdaqgbim is a newly disclosed equity position and the filing was required due to activity on may   this most probably shows biotechnology value fund l p’s confidence and optimism in the future of the company globeimmune inc hedge funds ownership latest sec filings show  hedge funds and institutional investors own globeimmune inc the institutional ownership of the company in q  is low at  of the shares outstanding they increased by  the total shares they hold as of that quarter these institutional investors owned  shares a total of  funds opened new positions in globeimmune inc and  increased their holdings there were  funds that closed their positions and  that reduced them charles davidson wexford capital lp is the most positive institutional investor on globeimmune inc with ownership of  shares as of q  for  of the fund’s portfolio ken greenberg and david kim ghost tree capital llc is another positive player owning  shares of the company or  of their stocks portfolio ca dafna capital management llc have  of their stock portfolio invested in the stock for  further woodstock corp disclosed it had purchased a stake worth  of the fund’s stock portfolio in the company the ny j goldman  company lp was also a notable investor in the firm owning  shares globeimmune inc is  of the fund’s stock portfolio company profile globeimmune inc globeimmune is a biopharmaceutical company the company is focused on developing therapeutic products for cancer and infectious diseases based on its tarmogen platform the company has four tarmogen product candidates in five ongoing clinical trials the company has two collaborations with biotechnology companies gilead sciences inc gilead exclusively licenses product candidates to treat chronic hepatitis b virus hbv infection celgene corporation celgene entered into collaboration with the company for certain oncology product candidates celgene exercises its option for across the world exclusive license to the gi program which is a tarmogens program targeting the brachyury protein the company has no products approved for commercial sale and as of september   it has not generated any product revenue form g is used when the filer owns between  and  of the company and plans to hold it only as a passive investor if the filler intend to exert control and if the stake’s size exceeds  then a d must be filed therefore activist investors and practices such as hostile takeovers company breakups and other “change of control” events are not permitted by g filers receive news  ratings via email  enter your email address below to receive a concise daily summary of the latest news and analysts ratings with marketbeatcoms free daily email newsletter tagged nasdaqgbim scripps eaton m sold scripps networks interactive inc’s shares scripps eaton m just decreased ew scripps co position free email newsletter enter your email address below to get the latest news and analysts ratings for your stocks with our free daily email newsletter hedge fund newstop  citadel advisors f holdings in q df dent  co inc just released its q  stock positionsmaverick capital top  holdings in q analyzing ken griffins citadel advisors stock holdings in q lone pine capital top  f positions in q guru newsfelix zulauf sees a stock market correction coming this rally sp  indexspinx will be shortlivedmarc faber shares his insight in one hour exclusive interview he covers all from commodities and china to inflation the euro and goldjim grant the next thing might be helicopter money what to buy and where he sees investment opportunitieskyle bass bearish on emerging markets for at least  more years looking to short currenciesdavid tepper gets defensive is it time to get out of the stock market macro newschina margin debt hits week high japan pumps’n’dumps as kyle bass fears looming em banking crisisare us – russian relations a zerosum gameus and russia have launched direct talks on the conflict in syriayuan drops as pboc cuts reference rate by most since devaluationcould the market crash like —put volume spike argues low is nearctas newsred rock just published report about the trend following landscape  how ctas’ performance must be analyzedhow to implement dual momentum for nonus investorsdo commodity trading advisors ctas really provide crisis alpha equity hedge and are long volatility biotechnology value fund l p  current holdings  fintelio biotechnology value fund l p current holdings from f d investorbiotechnology value fund l p managermark n lampert current positions biotechnology value fund l p has disclosed  total holdings in their latest sec filings portfolio managers are listed as mark n lampert this investor has not filed a f which indicates it has under m in assets under management aum this investor has filed  activist d filings recently which suggests it takes an active role in influencing management biotechnology value fund l p s top industries are chemicals and allied products sic   electronic and other electrical equipment and components except computer equipment sic   and miscellaneous retail  sic   overview sec filings dg predictive value all biotechnology value fund l p holdings are listed in the following table this data is sourced from dg and f filings green rows indicate new positions red rows indicate closed positions add this fundto your dashboard this is a list of d and g filings made since the last quarterly f report if any file dateformsecurity prevshares currentshares changepercent prev valuex current valuex changepercent ‑‑ sc ga rgls  regulus therapeutics inc     ‑‑ sc ga caps  capstone therapeutics corp     ‑‑ sc g ctmx  cytomx therapeutics inc     ‑‑ sc da ctic  cti biopharma corp     ‑‑ sc ga omed  oncomed pharmaceuticals inc     ‑‑ sc ga cytk  cytokinetics inc     ‑‑ sc ga bpmc  blueprint medicines corporation     ‑‑ sc g blrx  biolinerx ltd   ‑‑ sc d xoma  xoma corporation     ‑‑ sc ga anth  anthera pharmaceuticals inc     ‑‑ sc ga arql  arqule inc     ‑‑ sc ga pirs  pieris pharmaceuticals inc     ‑‑ sc ga imdz  immune design corp     ‑‑ sc ga snss  sunesis pharmaceuticals inc     ‑‑ sc ga glyc  glycomimetics inc     ‑‑ sc ga ccxi  chemocentryx inc     ‑‑ sc ga gtxi  gtx inc   ‑‑ sc ga cnce  concert pharmaceuticals inc     ‑‑ sc ga cbio  catalyst biosciences inc       ‑‑ sc ga nvls  nivalis therapeutics inc     ‑‑ sc ga xene  xenon pharmaceuticals inc     ‑‑ sc ga arry  array biopharma inc     ‑‑ sc ga vtae  vitae pharmaceuticals inc       ‑‑ sc g anab  anaptysbio inc   ‑‑ sc g casc  cascadian therapeutics inc     ‑‑ sc g onty  oncothyreon inc     ‑‑ sc ga infi  infinity pharmaceuticals inc     ‑‑ sc g fate  fate therapeutics inc   ‑‑ sc ga tbra  tobira therapeutics inc     ‑‑ sc g orex  orexigen therapeutics inc   ‑‑ sc ga qlti  qlt inc     ‑‑ sc ga sphs  sophiris bio inc   ‑‑ sc ga gbim  globeimmune inc     ‑‑ sc ga aols  aeolus pharmaceuticals inc   ‑‑ sc ga ogxi  oncogenex pharmaceuticals inc   ‑‑ sc ga ptn  palatin technologies inc   ‑‑ sc ga loxo  loxo oncology inc   fintel ir  find the right investors for your company instantly fintel ir combines the comprehensive fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy learn more now from the blog how to launch a hedge fund the piotroski score unauthorized access biotechnology value fund ii lp  san francisco  ca  company information products resources my account talk to a db advisor  business directory ca san francisco investment offices nec management investment funds closedend biotechnology value fund ii lp b biotechnology value fund ii lp claim this business  sansome st ste  san francisco ca  get directions   wwwgcmlpcom business info founded  incorporated annual revenue  employee count  industries management investment funds closedend contacts mark lampert contact business your email address subject message send message company summary biotechnology value fund ii lp was founded in  biotechnology value fund ii lp specializes in management investment funds closedend verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   b view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved biotechnology value fund lp  stock discussion forums stocktalkmarketspoliticspastimes biotech  medical biotechnology value fund lp an si board since january  posts subjectmarks bans    emcee  scaramouche type  moderated the original original post with a large snip which you can still access for this thread follows in italics the threads use has changed substantially since inception we now largely follow sector sentiment financing and liquidity there are occasional watch this development or watch this type of company commentsits now sort of a what will impact the sector going forward kind of thread were not a rahrah go biotech forum and critical commentary concerning valuations is frequent we will continue to discuss bvflampert and other fundsfund managers whichwho have distinct styles and whichwho impact the sector it is not a forum for companyspecific discussion unless it involves someone with deep pockets stumbling around in such an obvious fashion that nobrainer opportunities are created this thread established  is about mark n lampert his investments his method and his history all other contributions are strongly discouragedlampert has taken a recent bath nonetheless the guy has imo great taste in the future i expect his name to be mentioned in the same breath with those of soros buffett etc snipto start please list any positions that bvf has if you know of any that are under the  stake which triggers a sec filingdisclaimer ive never communicated with met or worked for lampertgorick previous   next   view recent  post message go to reply or date mmddyy replymessage previewfromposted fwiw bvf files a large mm share ownership in cytkmopgcw i think  is his babyrkrw so mark gets on the board to help not sure i recall hime being on one before mopgcw form k for aeolus pharmaceuticals inc oct other events item hmpa  im glad for this post message  the fda in general and cscaramouche best biotech name ever  san diego oct   globe newswire  fate theranigel bates bvf dumps a chunk of lgnd eommopgcw bvf does have a giant position in arry and a decent position in onty maybe bvfrkrw chuckle understood now i think it really isnt a bad deal  the warranmopgcw oh i see what you were asking yes above market i was joking as i had prevscaramouche warrants  its ironic but theyre already further outofmoney thscaramouche looks above market at share or am i missing somethingmopgcw saved my bacon today limit order throwing in some warrants rather than at mascaramouche you mean you dont work for steve cohen the dodgy ticker relatively large block dropped today between the bidask and i dont think iscaramouche dont think he saw it scaramouche wonderful subtlety rick the dodgy ticker mark lampert i met you many years ago a tour of your thensmall operation andscaramouche i thought the glaxo  avalon ventures deal announced is quite interesting a littmopgcw thanks wow surprisingscaramouche they held m shares pre stimuvax bomb so they added close to k to cross rkrw bvf goes over  for onty for those who follow the  positions could yoscaramouche morphosys ag  publication pursuant to § sect wphg the german securitigermanecki thank you rickscaramouche biotech vets back m a round for neuroscience startup april    by jsim previous   next   view recent  post message go to reply or date mmddyy homemailhotsubjectmarkspeoplemarkskeeperssettingsterms of usecontact uscopyrightip policyprivacy policyabout usfaqadvertise on sicopyright   knight sac media all rights reservedstock quotes are delayed at least  minutes  see terms of use insider trading  biotechnology value fund l p  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  biotechnology value fund l p select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing purchase  pm infinity pharmaceuticals inc infi bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbiotechnology value trading fund os lpbvf partners os ltdbvf inclampert mark n owner    direct view purchase  pm infinity pharmaceuticals inc infi bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbiotechnology value trading fund os lpbvf partners os ltdbvf inclampert mark n owner    direct view purchase  pm infinity pharmaceuticals inc infi bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbiotechnology value trading fund os lpbvf partners os ltdbvf inclampert mark n owner    direct view purchase  pm infinity pharmaceuticals inc infi bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbiotechnology value trading fund os lpbvf partners os ltdbvf inclampert mark n owner    direct view purchase  am cti biopharma corp ctic bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbiotechnology value trading fund os lpbvf partners os ltdbvf inclampert mark n owner    directindirect view sale  pm chemocentryx inc ccxi bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbvf inclampert mark nbvf investments llcother    indirect view sale  pm chemocentryx inc ccxi bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbvf inclampert mark nbvf investments llc owner    indirect view sale  pm chemocentryx inc ccxi bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbvf inclampert mark nbvf investments llc owner    indirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing option award  pm nana cascadian therapeutics inc onty lampert mark nbvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbiotechnology value trading fund os lpbvf partners os ltdbvf incdirector owner   direct view option award  pm nana cascadian therapeutics inc onty lampert mark nbvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbiotechnology value trading fund os lpbvf partners os ltdbvf incdirector owner   direct view option award  pm nana cascadian therapeutics inc onty lampert mark nbvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbiotechnology value trading fund os lpbvf partners os ltdbvf incdirector owner   direct view option award  pm nana cascadian therapeutics inc onty lampert mark nbvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbiotechnology value trading fund os lpbvf partners os ltdbvf incdirector owner   indirect view other  pm nana chemocentryx inc ccxi bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbvf inclampert mark nbvf investments llcother   indirect view other  pm nana oncothyreon inc onty bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbvf inclampert mark n owner   indirect view other  pm nana oncothyreon inc onty bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbvf inclampert mark n owner   indirect view other  pm na oncothyreon inc onty bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbvf inclampert mark n owner   indirect view other  pm na oncothyreon inc onty bvf partners l pbiotechnology value fund l pbiotechnology value fund ii lpbvf inclampert mark n owner   indirect view   secformcom all rights reserved archives        wed  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft united states personal investing trowepricecom personal investing workplace retirement institutional investor institutional consultant financial advisorintermediary recordkeeping sponsorconsultant log out log in open an account about us help my accounts portfolio transactions statements  documents profile mutual funds daily prices historical performance dividend distributions mutual fund research tool morningstar  and star rated funds stock funds bond funds target date funds asset allocation funds money market funds prospectuses  reports retirement ira rollover ira retirement planning required minimum distributions small business retirement plans b plans planning  research advice investing  asset allocation planning retirement planning college planning tax planning estate planning research  analysis t rowe price insights planning  resources charitable giving products  services activeplus portfolios college savings plans non retirement accounts private asset management select client services advisory planning services brokerage investor centers t rowe price value fund trvlx home  mutual funds t rowe price value fund print this page email this page text size new quarterly fund fact sheet now available ticker symbol trvlx fund status open to new retail investors    open to subsequent retail investments snapshot objective performance composition management expensesminimums compare fund snapshot quick stats current nav as of   nav change  daily ytd return as of   nav  month lowhigh    net assets as of   million morningstar ratings as of  overall  year  year  year morningstar rated the value fund among    and  large value funds for the overall rating and the   and year periods as applicable ending  respectively the overall morningstar rating for a managed product is derived from a weighted average of the performance figures associated with its three five and year if applicable morningstar rating metrics the weights are  threeyear rating for  months of total returns  fiveyear rating threeyear rating for  months of total returns and  year rating fiveyear rating threeyear rating for  or more months of total returns while the year overall star rating formula seems to give the most weight to the year period the most recent threeyear period actually has the greatest impact because it is included in all three rating periods performance comparison as of  this chart shows the value of a hypothetical  investment in the fund over the past  years or since its inception for funds lacking year records the result is compared with benchmarks which may include a broadbased market index and a peer group average or index market indexes do not include expenses which are deducted from fund returns as well as mutual fund averages and indexes benchmark definitions  the morningstar rating for funds or star rating is calculated for managed products including mutual funds variable annuity and variable life subaccounts exchangetraded funds closedend funds and separate accounts with at least a threeyear history exchangetraded funds and openended mutual funds are considered a single population for comparative purposes it is calculated based on a morningstar riskadjusted return measure that accounts for variation in a managed products monthly excess performance placing more emphasis on downward variations and rewarding consistent performance the top  of products in each product category receive  stars the next  receive  stars the next  receive  stars the next  receive  stars and the bottom  receive  star the overall morningstar rating for a managed product is derived from a weighted average of the performance figures associated with its three five and year if applicable morningstar rating metrics the weights are  threeyear rating for  months of total returns  fiveyear rating threeyear rating for  months of total returns and  year rating fiveyear rating threeyear rating for  or more months of total returns while the year overall star rating formula seems to give the most weight to the year period the most recent threeyear period actually has the greatest impact because it is included in all three rating periods source for morningstar data   morningstar inc all rights reserved the information contained herein  is proprietary to morningstar andor its content providers  may not be copied or distributed and  is not warranted to be accurate complete or timely neither morningstar nor its content providers are responsible for any damages or losses arising from any use of this information past performance is no guarantee of future results average annual total returns and benchmarks as of  benchmark definitions investment objective the fund seeks to provide longterm capital appreciation by investing in common stocks believed to be undervalued income is a secondary objective average annual total returns    monthend  quarterend   year    years    years    years   since inception   inception date september   gross expense ratio  net expense ratio  waiver type na limitation expires na current performance may be lower or higher than the quoted past performance which cannot guarantee future results share price principal value and return will vary and you may have a gain or loss when you sell your shares  average annual total return figures include changes in principal value reinvested dividends and capital gain distributions for funds less than one year old the since inception return figure is not annualized and represents an aggregate total return  the gross expense ratio reflects the fund expenses as stated in the fee table of the funds prospectus prior to the deduction of any waiver or reimbursement the net expense ratio reflects fund expenses after the deduction of any waiver or reimbursement if a fund has an active contractual expense ratio limitation the expiration date is shown below the gross and net expense ratio values above expense ratios are as of the most recent prospectus open an account transact  trade viewupdate accounts help center find a fund select fund by name africa  middle east  i cl africa  middle east fund asia opportunities asia opportunities  i cl balanced balanced  i cl blue chip growth blue chip growth  i cl california taxfree bond california taxfree bond  i cl california taxfree money california taxfree money  i cl capital appreciation capital appreciation  i cl capital opportunity capital opportunity  i cl cash reserves corporate income corporate income  i cl credit opportunities credit opportunities  i cl diversified midcap growth diversified midcap growth  i cl dividend growth dividend growth  i cl dynamic global bond dynamic global bond  i cl em mkts corporate bond  i cl em mkts local currency bond  i cl emerging europe emerging europe  i cl emerging markets bond emerging markets bond  i cl emerging markets corporate bond emerging markets local currency bond emerging markets stock emerging markets stock  i cl emerging markets value stock emerging markets value stock  i cl equity income equity income  i cl equity index  equity index   i cl european stock european stock  i cl extended equity market index financial services financial services  i cl floating rate floating rate  i cl georgia taxfree bond georgia taxfree bond  i cl global allocation global allocation  i cl global consumer global growth stock global growth stock  i cl global high income bond global high income bond  i cl global industrials global industrials  i cl global multisector bond global multisector bond  i cl global real estate  i cl global real estate fund global stock global stock  i cl global technology  i cl global technology fund gnma gnma  i cl government money government money  i cl growth  income growth  income  i cl growth stock growth stock  i cl health sciences health sciences  i cl high yield high yield  i cl inflation protected bond inflation protected bond  i cl intermediate taxfree high yield intermediate taxfree hy  i cl international bond international bond  i cl international concentrated eq  i cl international concentrated equity international discovery international discovery  i cl international equity index international stock international stock  i cl international value equity international value equity  i cl japan japan  i cl latin america latin america  i cl limited duration inflation focused bd lmtd duration infl focused bd  i cl maryland shortterm taxfree bond maryland shortterm txfr bnd  i cl maryland taxfree bond maryland taxfree bond  i cl maryland taxfree money maryland taxfree money  i cl media  telecommunications media  telecommunications  i cl midcap growth midcap growth  i cl midcap value midcap value  i cl new america growth new america growth  i cl new asia new asia  i cl new era new era  i cl new horizons new horizons  i cl new income new income  i cl new jersey taxfree bond new jersey taxfree bond  i cl new york taxfree bond new york taxfree bond  i cl new york taxfree money new york taxfree money  i cl overseas stock  i cl overseas stock fund personal strategy balanced personal strategy balanced  i cl personal strategy growth personal strategy growth  i cl personal strategy income personal strategy income  i cl qm global equity qm global equity  i cl qm us small  midcap core eq  i cl qm us small  midcap core equity qm us smallcap growth equity qm us smallcap growth equity  i cl qm us value equity qm us value equity  i cl real assets real assets  i cl real estate real estate  i cl retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement balanced fund retirement balanced i  i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement i   i cl retirement income  science  technology science  technology  i cl shortterm bond shortterm bond  i cl smallcap stock smallcap stock  i cl smallcap value smallcap value  i cl spectrum growth spectrum income spectrum international summit municipal income summit municipal intermediate summit municipal money market target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl target  target   i cl taxefficient equity  i cl taxefficient equity fund taxexempt money taxexempt money  i cl taxfree high yield taxfree high yield  i cl taxfree income taxfree income  i cl taxfree shortintermediate taxfree shortintermediate  i cl total equity market index total return total return  i cl us bond enhanced index us high yield us high yield  i cl us largecap core  i cl us largecap core fund us treasury intermediate us treasury intermediate  i cl us treasury longterm us treasury longterm  i cl us treasury money us treasury money  i cl ultra shortterm bond ultra shortterm bond  i cl value value  i cl virginia taxfree bond virginia taxfree bond  i cl select by ticker symbol gtfbx mdxbx njtfx nytxx otcfx otiix pbdix pccox pctxx pdgix pexmx pglox pgmsx pgtix pieqx pnaix pnsix pomix ppipx prafx pramx prasx prcix prcnx prcox prcpx prdgx prdmx prdsx prefx preix prelx premx presx prfdx prfhx prfrx prfsx prgfx prgix prgmx prgsx prgtx prhix prhsx prhyx pridx prihx prijx prikx prinx pripx prisx pritx priux prjix prjpx prkix prlax prmdx prmsx prmtx prnex prnhx prnyx prpix prrxx prscx prsgx prsix prsmx prsnx prsvx prtax prtix prtxx prufx pruix prulx pruux prvax prvix prwax prwbx prwcx prxax prxcx prxex prxix przix psilx ptexx ptkix pttfx ptyix rbaix rclix reipx revix rggix ricix rjaix rlaix rpbax rpeix rpgax rpgex rpgix rpgrx rpibx rpiex rpihx rpisx rpmgx rpoix rpsix rptfx rptix rpttx tbcix tbgax tbsix tcbxx tcfex tcrrx tecix teefx teimx terxx teuix tfaix tfbix tfbvx tfhax tfifx tfilx tfrrx tgafx tgipx tgtix thisx ticcx tiddx tiipx tirgx tirrx tmdxx toorx torfx tpgpx tppax tqaix tqgex tqgix tqmvx tqsix tqsmx tqvix traix tramx traox trarx trasx trbcx trbfx trbrx trbux trecx tremx trffx trfgx trfox trfwx trgax trglx trgrx trgxx trhrx trigx trjix trlax trldx trmcx trmix trmux trnex trnxx troix trosx trpax trpbx trpcx trpdx trpfx trphx trpix trpjx trpkx trplx trpmx trpnx trppx trptx trrax trrbx trrcx trrdx trrex trrfx trrgx trrhx trrix trrjx trrkx trrlx trrmx trrnx trrox trrtx trrux trrvx trrwx trsgx trstx trsxx trtfx trtix trulx trvlx trvvx trxrx tryix tscxx tsnix tteex ttgxx ttmix ttoix ttrtx ttsix tturx tuhix tuhyx twnxx twrrx more fund information download a prospectus download a semiannual report download an annual report download statement of additional information yearend dividend distributions yearend tax considerations dividend distribution dates   related links also available to certain investors as a lower cost i class mutual fund our mission is simple help clients around the world achieve their longterm investment goals connect with us facebook twitter youtube linkedin company overview responsibility careers investor relations press releases site map privacy policy terms of use security measures legal information customer agreement feedback mobile solutions contact us the mutual funds referred to in this website are offered and sold only to persons residing in the united states and are offered by prospectus only the prospectuses include investment objectives risks fees expenses and other information that you should read and consider carefully before investing download a prospectus wed jul   edt  all rights reserved t rowe price investment services inc distributor t rowe price mutual funds t rowe price invest with confidence and the bighorn sheep design are trademarks of t rowe price group inc all other trademarks are the property of their respective owners morningstar  and star rated funds  mutual funds  t rowe price  t rowe price home mutual funds morningstar  and star rated funds over  of our funds have earned  or star overall morningstar ratings as of  invest now call us at  download a prospectus morningstar  and star rated funds stock funds us stock funds international and global stock funds bond funds us bond funds international and global bond funds target date funds retirement funds target funds income funds asset allocation funds money market funds find a fund browse all t rowe price mutual funds many of our mutual funds earn morningstar’s highest ratings morningstar  and star rated funds because of our disciplined approach to investing morningstar a leader in independent investment research recognizes many of our mutual funds with its highest ratings in the funds respective categories over  of our funds have earned  or star overall morningstar ratings as of  morningstar uses a star system to rate mutual funds based on their riskadjusted returns five stars is the highest while one star is the lowest rating only the top  of all funds of the   get  stars and  get  stars are awarded morningstars  or star rating by comparison as of   of  of our rated funds investor class only received an overall rating of  or  stars​ past performance cannot guarantee future results view all  and star rated funds explore morningstar  and star rated funds fund nameticker morningstarcategory overall morningstarrating™ no offunds incategory riskrewardpotential fund name ticker morningstar category overall morningstar rating™ no of funds in category riskreward potential compare morningstar  and star rated funds find a fund browse all t rowe price mutual funds t rowe price insightsreg markets  economy monthly market review stay informed about global economic developments and our perspective on market conditions read more   source t rowe price markets  economy global markets weekly update keep uptodate on our views on developments in global capital markets read more july    source t rowe price all mutual funds are subject to market risk including possible loss of principal morningstar gives its best ratings of  or  stars to the top  of all funds of the   get  stars and  get  stars based on their riskadjusted returns the overall morningstar rating™ is derived from a weighted average of the performance figures associated with a funds   and year if applicable morningstar rating™ metrics as of   of  of our rated funds investor class only received an overall rating of  or  stars the morningstar ratingtm for funds or star rating is calculated for funds with at least a threeyear history exchangetraded funds and openended mutual funds are considered a single population for comparative purposes it is calculated based on a morningstar riskadjusted return measure that accounts for variation in a managed products monthly excess performance placing more emphasis on downward variations and rewarding consistent performance the top  of products in each product category receive  stars the next  receive  stars the next  receive  stars the next  receive  stars and the bottom  receive  star source for morningstar data  morningstar inc all rights reserved the information contained herein  is proprietary to morningstar andor its content providers  may not be copied or distributed and  is not warranted to be accurate complete or timely neither morningstar nor its content providers are responsible for any damages or losses arising from any use of this information past performance is no guarantee of future results this chart displays relative risk of each us mutual fund listed using standard deviation of returns those values are provided in the bars at the top of the chart methodology we evaluate the standard deviation and its resulting placement within a specific riskreturn category on an annual basis a fund is generally placed in a riskreturn category based on the year standard deviation of its performance if a fund is less than  years old the actual fund performance history is supplemented with the primary prospectus benchmark history to obtain a full year history or longest time period available up to  years for an asset allocation fund with less than  years of performance history substrategy returns are used when a substrategy is less than  years old the actual substrategy performance history is supplemented with benchmark history to obtain a full year history or longest time period available up to  years risk return categories overlap a fund with a standard deviation in the overlap between two categories denoted by a plus  is placed so that its risk categorization is better aligned with anticipated return characteristics an investor may experience going forward at the discretion of t rowe price when a fund has a cashlike benchmark denoted by a double plus  its standard deviation is estimated using only available fund returns if the fund is less than  years old benchmark returns are not used to obtain a full year history because they would artificially suppress the volatility estimate all investments are subject to market risk including the possible loss of principal standard deviation of returns a measure of price volatility is one measure of risk please consult the funds’ prospectuses for a more complete discussion of the funds’ risks  california taxfree money fund capital appreciation fund equity income fund global allocation fund global industrials fund gnma fund inflation protected bond fund international bond fund international stock fund japan fund limited duration inflation focused bond fund new era fund personal strategy balanced fund personal strategy income fund qm global equity fund qm global equity fund qm us value equity fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund retirement  fund shortterm bond fund spectrum international fund summit municipal intermediate fund target  fund target  fund target  fund target  fund target  fund taxfree shortintermediate fund total equity market index fund ultra shortterm bond fund  global unconstrained bond fund roth or traditional ira  t rowe price home retirement ira roth or traditional ira roth or traditional ira compare roth and traditional iras roth ira traditional ira roth or traditional ira rollover and transfer iras navigate to roth ira traditional ira roth or traditional ira rollover and transfer iras when it comes to making a thoughtful decision between a roth ira and a traditional ira it helps to understand the differences   roth ira traditional ira taxes contributions made are not deductible contributions made can be taxdeductible or nondeductible deductibility of contributions depends on active participation in a retirement plan and your modified adjusted gross income magi not exceeding certain amounts withdrawal of contributions withdraw anytime without taxes or penalties withdraw anytime but deductible contributions are taxable and generally subject to penalties if withdrawn before age ½ withdrawal of earnings tax and penaltyfree when withdrawn at age ½ if account has been active for at least five years taxable when withdrawn and generally subject to penalties if withdrawn before age ½ age restrictions none   must be under age ½ during the tax year of the contribution eligibility may contribute only if depending on filing status magi does not exceed certain amounts you must have us earned income no restrictions on contributions you must have us earned income   required minimum distributions rmds none during your lifetime must begin taking for the year in which you reach age ½ ready to start call  open a roth ira open a traditional ira still unsure about roth vs traditional answer four questions to find out which ira may be right for you why t rowe price for a roth or traditional ira low fees and minimums   you need to maximize your return potential so we work to keep our fees competitive thats why our solutions include noload mutual funds with low expense ratios keep in mind that a traditional iraroth ira may be subject to an annual fee and a fee may be assessed when a traditional iraroth ira is closed heres more information on fees convenient and flexible fund choices   you can choose from target date funds with strategic asset allocation and diversification or select from more than  mutual funds to suit your investing needs download a prospectus a global investing network in pursuit of your goals   our highly tenured global investment professionals are continuously assessing potential risk while identifying opportunities to maximize growth potential over the long term so you have more money in retirement  want to move existing savings into a roth ira roll over a k a rollover ira is one of several options to consider for your former workplace retirement plan such as a k   explore your options roll over now   transfer an existing ira if you decide to transfer an ira we offer over  mutual funds from which to choose and we make it easy by handling most of the paperwork too transfer an ira now convert your t rowe price traditional ira to a roth ira a roth ira offers many advantages over a traditional ira like potentially taxfree withdrawals if you need them convert now microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft biotech bull  bear x etf  labu labd  direxion brzu daily msci brazil bull x shareschad daily csi  china a share bear x shareschau daily csi  china a share bull x sharesclaw daily homebuilders  supplies bear x sharescom direxion auspice broad commodity strategy etfcure daily healthcare bull x sharescweb daily csi china internet index bull x sharesdfen daily aerospace  defense bull x sharesdpk daily msci developed markets bear x sharesdpst daily regional banks bull x sharesdrip daily sp oil  gas exp  prod bear x sharesdrn daily msci real estate bull x sharesdrv daily msci real estate bear x sharesdull daily silver miners index bear x sharesdusl daily industrials bull x sharesdust daily gold miners index bear x sharesdxcbx direxion indexed cvt strategy funddxcix direxion indexed commodity strategy fund – instdxctx direxion indexed commodity strategy fund – adxelx monthly emerging markets bull x funddxhlx monthly china bull x funddxhyx monthly high yield bull x funddxklx monthly  year treasury bull x funddxksx monthly  year treasury bear x funddxltx monthly  year treasury bull x funddxmax direxion indexed managed futures strategy fund – adxmcx direxion indexed managed futures strategy fund – cdxmix direxion indexed managed futures strategy fund – instdxnlx monthly nasdaq bull x funddxnsx monthly nasdaq bear x funddxqlx monthly nasdaq bull x funddxrlx monthly small cap bull x funddxrsx monthly small cap bear x funddxscx direxion indexed commodity strategy fund – cdxslx monthly sp  bull x funddxssx monthly sp  bear x funddxstx monthly  year treasury bear x funddzk daily msci developed markets bull x sharesedc daily msci emerging markets bull x sharesedz daily msci emerging markets bear x shareserx daily energy bull x sharesery daily energy bear x shareseryy daily energy bear x shareseufl daily msci european financials bull x shareseufs daily msci european financials bear x shareseurl daily ftse europe bull x shareseuxl daily euro stoxx  bull x sharesfas daily financial bull x sharesfaz daily financial bear x sharesfazz daily financial bear x sharesgasl daily natural gas related bull x sharesgasx daily natural gas related bear x sharesgush daily sp oil  gas exp  prod bull x shareshakk daily cyber security  it bull x shareshcyax direxion hilton tactical income fund – a shareshcycx direxion hilton tactical income fund – c shareshcyix direxion hilton tactical income fund – institutionalhydd daily high yield bear x sharesibln direxion ibillionaire index etfindl daily msci india bull x sharesjdst daily junior gold miners index bull x sharesjdst daily junior gold miners index bear x sharesjpnl daily msci japan bull x sharesknow direxion all cap insider sentiment shareskoru daily msci south korea bull x shareslabd daily sp biotech bear x shareslabs daily sp biotech bear x shareslabu daily sp biotech bull x shareslbj daily latin america bull x sharesllsc daily small cap bull x sharesllsp daily sp  bull x sharesmelt daily gold miners index bear x sharesmexx daily msci mexico bull x sharesmidu daily mid cap bull x sharesmidz daily mid cap bear x sharesnail daily homebuilders  supplies bull x sharesnugt daily gold miners index bull x sharespemvx evolution managed fundsqqqe direxion nasdaq equal weighted index sharesretl daily retail bull x sharesrusl daily russia bull x sharesruss daily russia bear x sharessagg daily total bond market bear x sharesshny daily silver miners index bull x sharessick daily healthcare bear x sharessmll daily small cap bull x sharessoxl daily semiconductor bull x sharessoxs daily semiconductor bear x sharesspdn daily sp  bear x sharessplz daily consumer staples bear x sharesspuu daily sp  bull x sharesspxl daily sp  bull x sharesspxs daily sp  bear x sharestecl daily technology bull x sharestecs daily technology bear x sharestecz daily technology bear x sharestmf daily  year treasury bull x sharestmv daily  year treasury bear x sharestna daily small cap bull x sharestpor daily transportation bull x sharestybs daily  year treasury bear x sharestyd daily  year treasury bull x sharestyns daily  year treasury bear x sharestyo daily  year treasury bear x sharestza daily small cap bear x sharesutlz daily utilities bear x sharesutsl daily utilities bull x shareswdrw daily regional banks bear x sharesyang daily ftse china bear x sharesyinn daily ftse china bull x shareszmlp direxion zacks mlp high income index shares direxion daily sp biotech bull and bear x shares fund symbol labu daily target  intraday indicative value labuiv bloomberg index spsibitr cusip k isin usk expense ratio grossnet     inception date may   fund symbol labd daily target  intraday indicative value labdiv bloomberg index spsibitr cusip k isin usk expense ratio grossnet     inception date may   overview the direxion daily sp biotech bull and bear x shares seek daily investment results before fees and expenses of  or  of the inverse or opposite of the performance of the sp biotechnology select industry index there is no guarantee the funds will meet their stated investment objectives these leveraged etfs seek a return that is  or  of the return of their benchmark index for a single day the funds should not be expected to provide three times or negative three times the return of the benchmark’s cumulative return for periods greater than a day labu labd fact sheet etf guide labu prospectus labd prospectus premium discount daily holdings download labu daily holdings csv download labd daily holdings csv daily holdings labu     daily sp biotech bull x shares trade date     shares outstanding  stock ticker security description shares price market value — bank of new york cash reserve    — dreyfus govt cash mgmt    — dreyfus govt cash mgmt    — dreyfus govt cash mgmt    — goldman finl sq trsry inst     — goldman finl sq trsry inst     — sp biotechnology select industry index swap    — sp biotechnology select industry index swap    — sp biotechnology select industry index swap    — sp biotechnology select industry index swap    — sp biotechnology select industry index swap    xbi spdr sp biotech etf    labd     daily sp biotech bear x shares trade date     shares outstanding  stock ticker security description shares price market value — bank of new york cash reserve    — dreyfus govt cash mgmt    — dreyfus govt cash mgmt    — dreyfus govt cash mgmt    — goldman finl sq trsry inst     — goldman finl sq trsry inst     — sp biotechnology select industry index swap    — sp biotechnology select industry index swap    — sp biotechnology select industry index swap    strategy  benefits key benefits you know that trading is different than investing but the opportunity to take advantage of shortterm trends is only won if you get the direction right whether you’re a bull or a bear direxion is with you our leveraged etfs are powerful tools built to help you magnify your shortterm perspective with daily x leverage go where there’s opportunity with bull and bear funds for both sides of the trade and stay agile – with liquidity to trade through rapidly changing markets leveraged and inverse etfs pursue daily leveraged investment objectives which means they are riskier than alternatives which do not use leverage they seek daily goals and should not be expected to track the underlying index over periods longer than one day they are not suitable for all investors and should be utilized only by investors who understand leverage risk and who actively manage their investments target index the sp biotechnology select industry index spsibitr is provided by standard  poor’s and includes domestic companies from the biotechnology industry the index is designed to measure the performance of the biotechnology subindustry based on the global industry classification standards gics one cannot directly invest in an index index top ten holdings  clovis oncology inc  exelixis inc  kite pharma inc  alexion pharmaceuticals inc  celgene corp  alnylam pharmaceuticals inc  gilead sciences inc  sarepta therapeutics inc  bioverativ inc  exact sciences corp  index sector weightings  medicalbiomedicalgenetics  medicaldrugs  therapeutics  medicalgeneric drugs  diagnostic kits  medical products  diagnostic equipment  drug delivery systems  index data as of  source bloomberg index sector weightings and top holdings are subject to change tax reporting supplemental tax documents  – ordinary income from us government obligations labd pricing and performance pricing and performance nav and market price information as of july   line chart shows pricing trend over the last  days fund symbol labu net asset value nav  nav   change   change  market price closing  market   change   change  premium  discount   change from last day trading fund symbol labd net asset value nav  nav   change   change  market price closing  market   change   change  premium  discount   change from last day trading monthly quarterly as of june   as of june   labu daily sp biotech bull x shares m  m  ytd  y  since inception inception date expense ratio  gross  net  m  m  ytd  y  since inception inception date expense ratio  gross  net  nav          market close      nav          market close      spsibitr benchmark index        labd daily sp biotech bear x shares m  m  ytd  y  since inception inception date expense ratio  gross  net  m  m  ytd  y  since inception inception date expense ratio  gross  net  nav          market close      nav          market close      spsibitr benchmark index         the net expense ratio includes management fees other operating expenses and acquired fund fees and expenses if acquired fund fees and expenses were excluded the net expense ratio would be  the funds’ adviser rafferty asset management llc “rafferty” has entered into an operating expense limitation agreement with each fund under which rafferty has contractually agreed to cap all or a portion of its management fee andor reimburse each fund for other expenses through september   to the extent that the fund’s total annual fund operating expenses exceed  of the fund’s daily net assets other than the following taxes swap financing and related costs acquired fund fees and expenses dividends or interest on short positions other interest expenses brokerage commissions and extraordinary expenses if these expenses were included the expense ratio would be higher the performance data quoted represents past performance past performance does not guarantee future results the investment return and principal value of an investment will fluctuate an investor’s shares when redeemed may be worth more or less than their original cost current performance may be lower or higher than the performance quoted returns for performance under one year are cumulative not annualized for the most recent monthend performance please visit the funds website at direxioninvestmentscom shortterm performance in particular is not a good indication of the fund’s future performance and an investment should not be made based solely on returns because of ongoing market volatility fund performance may be subject to substantial shortterm changes for additional information see the fund’s prospectus distributions distributions labu daily sp biotech bull x shares there are no recent distributions available for this fund labd daily sp biotech bear x shares there are no recent distributions available for this fund related reading knowledge related education articles and insights etf market pricing etf market prices are the prices at which investors buy or sell shares of an etf in the secondary market while etfs are designed to trade in line with their intraday values during times of significant market volatility an etf’s market price may vary more widely from its intraday value etf liquidity – four rules to consider liquidity transparency realtime trading and relatively low management fees are the reason why etfs are becoming more and more popular learn about the four key characteristics that investors should better understand in order to trade them properly more articles like this search engine marketing sem  bing ads skip to content sign upsign in   you run your business well help find your customers bing ads can help build your business and drive your success spend  and get  in advertising credit† †offer details get  in search advertising when you spend  in bing ads coupon code class first name last name email your website url business phone required microsoft may contact you to provide updates and special offers about bing ads you can unsubscribe at any time to learn more you can read the privacy statement type the code from the image enter security code   × get  in search advertising when you spend  in bing ads †offer details offer expires december   valid only for new bing ads customers who are first party recipients of the offer email a new bing ads customer is one that has not advertised on bing ads before enter promotional coupon code and spend  applies to threshold and prepaid accounts to receive  in bing ads credits limit one promotion code per new bing ads customer promotional code must be redeemed within thirty  days of bing ads new customer account creation ad campaign costs accrued before receiving a credit as well as costs accrued after all credits are used will be charged to the payment method associated with the bing ads account if customer payment fails the coupon amount will not be applied ads will continue to run and accrue costs after any promotional credit has been used up any portion of the credit not used within ninety  days of credit redemption will expire and cant be carried over even if the bing ads customer switches their payment method offer valid only to residents of the united states in order for the offer to be valid a form of payment must be entered into your account prior to redemption of the promotional code and prior to your account going live to take advantage of the credit this offer may not be combined with any other offer promotional code coupon or discount separated redeemed for cash transferred sold or bartered microsoft in its sole discretion can close your account for any suspected coupon abuse refund of the  is not permitted see bing ads terms and conditions for more details at signup other terms and conditions may apply microsoft reserves the right to cancel change or suspend this offer at any time without notice see how bing ads works customers search customers see your ad customers contact you watch how bing ads works     × how bing ads works help more customers find you see how bing can attract customers your google adwords campaigns cant reach  million searchers on the bing network tap into  of the search marketplace get in front of searchers who spend  percent more than the average internet searcher powerful network powerful benefits reach across devicesconnect with customers looking for your business anytime anywhere on any device go global or localreach people in the bing network everywhere or focus on cities counties and areas within a certain distance from your business easy to importif youre already using another product like google adwords its easy to pull that campaign into bing ads you control your costs  free signupjoin bing ads for free and control your account at every step  only pay for clickspay just when customers click on your ad no click no charge  no minimum feestart advertising with a budget that works best for your business   the advantage we gain in cost per click gives us a great return on investment — more than  percent better than google adwords scott redgate search engine marketing manager — cj pony parts by using bing ads features like image extensions and sitelink extensions this auto parts retailer races to convert customers and beat its competition  read about driving more conversions   we might not get as much of the volume as with google adwords but the volume of the traffic that we get converts really well at a lower cost scott schult executive vice president of marketing — myrtle beach area convention and visitors bureau the myrtle beach area convention and visitors bureau uses bing ads to drive site traffic and tourism at lower cost  read about getting better roi better results for less cost thats as simple as i can make it if i look at the quality of the traffic we get for the dollars we spend on bing ads our roi is fantastic alex littlewood ceo   motoroso motoroso a market network for auto enthusiasts gets better results for less cost and reaches a highvalue audience with bing ads  read about attracting quality traffic   import your adwords campaigns save time by importing your google adwords campaigns into bing ads to get ads live quickly sign in with your microsoft account or create one to get started on bing ads from within the bing ads interface select the import from google adwords option enter your google adwords credentials and select the campaign you want to import preview your ad get found online with search engine marketing make the most of your marketing dollars and drive customers to your business see how bing ads can work for you get started today give us a few details about your business to create a bing ads account and get it up and running   sign up get started with bing ads signing up is always free faq is bing ads right for me is bing ads right for my business all types of businesses find value and success with bing ads whether youre focused on local calls and foot traffic or want to drive traffic to your website from across the country or around the world bing ads has solutions for you i already appear in search results for free why should i pay for advertising your current customers may search for your business by name aiming it easy to find you in search results but customers youve yet to reach are more likely searching for general terms that wouldnt necessarily bring up your business in search results advertising next to relevant bing search results puts your business front and center with interested customers you otherwise might not reach what is the difference between seo and sem which one is right for me search engine optimization seo is adjusting your website to improve your natural ranking in search results you cannot pay to improve your website ranking on bing or yahoo thus we often refer to these results and unpaid or organic search results clicks from seo are free but seo also requires technical expertise and involves some factors over which you have only limited control search engine marketing sem is paid advertising that appears next to or above unpaid or organic search results these paid ads are purchased through bing ads you pay for sem clicks but sem gives you more control over when your website appears on results pages and you decide how much you want to pay and you can measure which ads are working and quickly improve your results you dont have to choose between seo and sem you can do both if my time is limited should i still try bing ads yes call a bing ads specialist at and we’ll set up your first campaign for you for free we’ll give you tips on getting the most out of your ads and set you up for success we’re here to help about bing ads where does my ad appear your ads could appear on the top or to the right of bing yahoo and msn search results and you can choose to target your ads to different geographic regions times or days of the week and even demographics what determines my ad position bing ads is a payperclick ppc advertising system you bid based on how much you are willing to pay per each click on your ad because webpages have a limited number of places to show ads we auction those spaces you are bidding against other advertisers to get your ads into the space you want so if you bid on the keyword shoe you will have to beat the bids of the other advertisers who are also bidding on shoe you determine how much you are willing to bid your ad position is based on several things including how closely your ad and website fit with the terms that are searched relevance how your bid compares to other bids in the bing ads auction how strongly your ad has performed in the past and how often it has been clicked clickthrough rate the stronger you are in these areas the better your chances of winning the top ad position how to use bing ads how can i use bing ads to drive more people to my website here are some tips to get better results review your budget and bid strategy if your ad keeps pausing your budget limit may be set too low competitive bids help your ad stay in a strong position to catch eyes and get more clicks to your website expand your targeting both for location and for devices computer mobile and tablet make sure your ads and website are relevant to the keywords you bid on would someone searching your terms expect to see and ad for your business how can i keep my costs down while your first instinct may be to lower your budget first try lowering your maximum bids yes this could mean fewer customers visit your site but if you increase your quality score and build ads with a strong performance history you may be able to win a good ad position with a lower bid that would lower your costperclick and help stretch your budget how do i know if bing ads is working view a wide range of performance trends in your account to quickly see key stats ad clicks the number of times your ad appeared impressions spend average costperclick clickthrough rate average ad position cost per acquisition and conversions you can also run performance reports to get insights into how well your campaigns are doing can i run more than one ad yes in fact we encourage it only one ad will show at a time but running multiple ads lets you test different approaches to see whats working best with your target customers frequently businesses try out different ads for specific products or pages getting started with bing ads how do i get started sign up for bing ads which keywords should i choose you have a few options to help choose your keywords first youll want to think of the terms one of your customers might use to search for your products and offerings those search terms are a great starting point then you can use tools right in your account to find more keywords within bing ads click campaigns on the top of the page click the keywords tab and then click add keywords this will let you search for new keywords based on one you enter search a website for keywords search your destination urls for keywords how can i write a good ad here are a few tips that can help make your ad stand out keep your ads relevant one way to improve relevance is to use your customers most popular search terms in your ad titles and txt describe what sets your product apart use your customers language use words and writing tone that are likely to attract your typical customer be specific this clearer and more specific your offering the better for example rather than big discount specify and exact percentage such as  percent off give customers a reason to click your ad right now offer a specific call to action such as encouraging customers to request a brochure or consultation download a free ebook subscribe to a newsletter or take advantage of a limitedtime discount sign up with bing ads to get started